MYOF and colorectal carcinoma: proposed that targeting vesicle trafficking-related protein myoferlin could be a promising opportunity to treat CRC clinically, as myoferlin suppressed exosome secretion and internalization and thereby reduced the invasive capacity of tumor cells (187).